Search results
Results From The WOW.Com Content Network
The journal publishes across a variety of disciplines with the inclusion of research on traditional, behavioural, cognitive, and biological assessment; diagnosis and classification, psychosocial and psychopharmacological treatment, genetics, epidemiology, and prevention. Theoretical and review articles contributing to the advancement of ...
Depression and Anxiety is a monthly peer-reviewed medical journal published by Wiley-Blackwell.It is an official journal of the Anxiety and Depression Association of America and covers research on depressive and anxiety disorders.
The Anxiety and Depression Association of America (ADAA) is a U.S. nonprofit organization located in Silver Spring, Maryland [7] dedicated to increasing awareness of and improving the diagnosis, treatment, and cure of anxiety disorders in children and adults. The organization is involved in education, training, and research for anxiety and ...
Separation anxiety disorder (SepAD) is the feeling of excessive and inappropriate levels of anxiety over being separated from a person or place. Separation anxiety is a normal part of development in babies or children, and it is only when this feeling is excessive or inappropriate that it can be considered a disorder. [37]
Members of the site each have a user profile and can upload research output including papers, data, chapters, negative results, patents, research proposals, methods, presentations, and software source code. Users may also follow the activities of other users and engage in discussions with them.
Exposure therapy is a technique in behavior therapy to treat anxiety disorders. Exposure therapy involves exposing the patient to the anxiety source or its context (without the intention to cause any danger). Doing so is thought to help them overcome their anxiety or distress.
The programs aim to increase social and emotional skills, promote resilience, and preventing anxiety and depression across the lifespan. As a prevention protocol, FRIENDS has been noted as “one of the most robustly-supported programmes for internalising disorders,” with “a number of large-scale type 1 randomised control trials worldwide ...
Both of them are considered as first-line anti-anxiety medications. TCAs are second-line treatment as they cause more significant adverse effects when compared to the first-line treatment. Benzodiazepines are effective in emergent and short-term treatment of anxiety disorders due to their fast onset but carry the risk of dependence. [4]